IGF1 and type 2 diabetes mellitus: -mediated repression of IGF-1 signalling through PTP1B and PTEN activation might have salutary effects on cells with perturbed mitochondria as is the case in type 2 diabetes mellitus, ageing, impaired wound healing, and neurodegenerative disease.